The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that ...

After implantation, patients are able to return home with the therapy activated; no daily interventions or manual adjustments are required. The Food and Drug Administration (FDA) has cleared Medtronic ...

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...

The FDA has cleared InTone, a medical device for treating female urinary incontinence. InTone is the first medical device that combines mild micro-current stimulation (similar to a transcutaneous ...

Medtronic has received FDA approval for a new implant aimed at improving bladder control, with a small device placed near the ankle designed to be more convenient and accessible. Compared to other ...

Urinary and bowel disorders, manifesting as symptoms like frequent urination or difficulty in bowel movements, can greatly impact one’s quality of life, even though they are not outwardly visible.

New York, April 23, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Urinary Incontinence Device Market - Premium Insight, Competitive News Feed Analysis, Company ...